Remote Patient Management of CIEDs
Launched by RATIKA PARKASH · Jan 15, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to manage patients with heart rhythm problems using remote technology. Specifically, it looks at how well patients do when they are monitored from home with their defibrillator devices compared to the usual in-person doctor visits. Patients will be divided into two groups: one will use remote monitoring, while the other will continue with standard care. The trial is being conducted in multiple centers across Canada and aims to see if this remote management can improve patient care.
To be eligible for this trial, participants need to have a Medtronic or Abbott defibrillator that can be monitored remotely. They must also be able to give their consent to join the study. However, individuals without a family doctor, those who can't be referred to a heart specialist, or who are already being monitored more frequently than every six months by a heart clinic will not qualify. If you join the study, you can expect regular check-ins to monitor your heart condition and to provide feedback on your experience with remote management. This trial is currently recruiting participants of all genders, aged between 65 and 74.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients with a Medtronic, Abbott or Boston Scientific defibrillator/CRT-D capable of remote monitoring with Carelink, Merlin or Latitude.
- • 2. Able to provide consent.
- • 3. Age \>/= 18 years
- Exclusion Criteria:
- • 1. No family physician or general practitioner
- • 2. Inability to be referred to a specialist
- • 3. Currently followed more than every 6 months by a Heart Function Clinic
- • 4. Participation in another randomized clinical trial that impacts outcome
- • 5. Unreliable automated capture verification by device in pacemaker dependent patient
About Ratika Parkash
Ratika Parkash is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative therapeutic solutions. Committed to rigorous scientific standards and ethical practices, the organization collaborates with leading healthcare professionals and research institutions to design and implement clinical trials across various therapeutic areas. With a strong emphasis on patient safety and data integrity, Ratika Parkash aims to contribute valuable insights to the medical community, ultimately enhancing treatment options and quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sherbrooke, Quebec, Canada
Calgary, Alberta, Canada
Montreal, Quebec, Canada
Saint John, New Brunswick, Canada
London, Ontario, Canada
Winnipeg, Manitoba, Canada
Kitchener, Ontario, Canada
Halifax, Nova Scotia, Canada
Newmarket, Ontario, Canada
Montreal, Quebec, Canada
Québec, Quebec, Canada
Victoria, British Columbia, Canada
Patients applied
Trial Officials
Ratika Parkash, MD FRCPC
Principal Investigator
Nova Scotia Health Authority
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials